Based on the information available, there doesn't seem to be a clear confirmation that the Vascepa discount program is available for all patients. The details of the program, such as eligibility criteria and availability, are typically not publicly disclosed and may vary.

Vascepa, a prescription medication used to lower triglyceride levels, is manufactured by Amarin Pharma Inc. According to Amarin's Patient Assistance Program page [1], the company offers programs to help eligible patients access Vascepa at an affordable cost. However, it does not explicitly state that the program is available for all patients.

Additionally, DrugPatentWatch.com [2] provides information on patents and exclusivities related to Vascepa, but it does not offer specific details about the discount program.

In conclusion, while there are assistance programs available for Vascepa, it is not explicitly stated that they are available for all patients. Interested individuals should contact Amarin Pharma Inc. or their healthcare provider for more information on the Vascepa discount program and eligibility requirements.

Sources:
[1] Amarin Pharma Inc. (n.d.). Patient Assistance Program. Retrieved from <https://www.amarin.com/patients/patient-assistance-program>
[2] DrugPatentWatch.com. (n.d.). Vascepa (Icosapent Ethyl). Retrieved from <https://www.drugpatentwatch.com/drugs/vascepa>